State Street’s Passage Bio PASG Stock Holding History
Bought
Maintained
Sold
Other funds holding PASG
LCM
VPC
EAM
NLVP
TCM
O
State Street's PASG Position: Q3 2025 in Review
State Street sold out of Passage Bio (PASG) in Q3 2025, closing a stake of 7,839 shares — an estimated $62.8K sold.
State Street first reported a position in PASG in Q2 2020 and held it in 21 quarters. The position peaked at $31.2M in Q1 2021. 32 funds tracked by Wall St. Rank hold PASG as of Q3 2025.
- State Street reported no remaining Passage Bio position as of Q3 2025 after selling out during the quarter.
- State Street sold 7,839 Passage Bio shares in Q3 2025, an estimated $62.8K.
- State Street first reported a position in Passage Bio in Q2 2020 and held it in 21 quarters.
- State Street's Passage Bio position peaked at $31.2M in Q1 2021.
- 32 funds tracked by Wall St. Rank held Passage Bio as of Q3 2025.
Based on State Street's 13F filing for Q3 2025, filed 14 Nov 2025.